Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Pericyte PDGFR-β deficiency contributes to Aβ pathology through impaired glymphatic transport and altered AQP-4 localization.

Created on 18 Nov 2026

Authors

Hai-Chao Chen, Fu-Lin Gao, Can He, Min-Hua Yao, Ya-Xuan Shi, Si-Wei Zhou, Xiao-Yu Zhang, Chuan-Xiong Li, Li-Ping Gao, Yu-Hong Jing

Published in

Alzheimer's & dementia : the journal of the Alzheimer's Association. Volume 22. Issue 11.

Abstract

Pericyte platelet-derived growth factor receptor-β (PDGFR-β) signaling maintains neurovascular integrity, but its role in glymphatic function is unknown. We investigated whether pericyte PDGFR-β deficiency is associated with glymphatic dysfunction and altered aquaporin-4 (AQP-4) localization in Alzheimer's disease (AD).
Glymphatic trafficking was assessed by fluorescent cerebrospinal fluid (CSF) tracer injection. Meningeal lymphatic drainage was blocked by deep cervical lymph node (dcLN) ligation. Pericyte coverage, AQP-4 expression/localization, and basement membrane components were analyzed by immunofluorescence and western blot. Pericyte-conditioned medium was used to examine the effects of pericyte-derived factors on astrocytic AQP-4. The AQP-4 facilitator TGN-073 was administered to assess functional rescue. Blood-brain barrier integrity, microvascular density, and cerebral blood flow were also evaluated.
DcLN ligation impaired amyloid beta clearance and spatial memory. Both APP/PS1 and Pdgfr-β+/- mice exhibited pericyte loss and glymphatic dysfunction, with Pdgfr-β+/- mice additionally showing reduced perivascular AQP-4 expression, accompanied by decreased laminin-α2/β1. In vitro, pericyte-derived factors promoted AQP-4 expression. TGN-073 partially improved small-molecule CSF tracer distribution in Pdgfr-β+/- mice. Pdgfr-β+/-/APP/PS1 mice displayed exacerbated AD-like pathology.
PDGFR-β deficiency compromises basement membrane integrity and AQP-4 localization, impairing glymphatic transport and accelerating AD pathogenesis. The PDGFR-β pathway may represent a novel therapeutic target for enhancing waste clearance.

PMID:
43046622
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement